We assign a fundamental rating of 0 out of 10 to SISI. SISI was compared to 36 industry peers in the Personal Care Products industry. SISI may be in some trouble as it scores bad on both profitability and health. SISI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year SISI has reported negative net income.
In the past year SISI has reported a negative cash flow from operations.
SISI had negative earnings in each of the past 5 years.
In the past 5 years SISI always reported negative operating cash flow.

1.2 Ratios

SISI has a Return On Assets of -45.50%. This is amonst the worse of the industry: SISI underperforms 83.33% of its industry peers.
SISI has a worse Return On Equity (-214.17%) than 80.56% of its industry peers.

		Industry Rank	Sector Rank
ROA	-45.5%
ROE	-214.17%
ROIC	N/A

ROA(3y)-30.03%

ROA(5y)-29.95%

ROE(3y)-69.19%

ROE(5y)-57.61%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SISI's Gross Margin of 6.95% is on the low side compared to the rest of the industry. SISI is outperformed by 88.89% of its industry peers.
SISI's Gross Margin has declined in the last couple of years.
SISI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	6.95%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-20.72%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SISI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SISI has been increased compared to 1 year ago.
The number of shares outstanding for SISI has been increased compared to 5 years ago.
Compared to 1 year ago, SISI has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.73, we must say that SISI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SISI (-1.73) is worse than 88.89% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that SISI is somewhat dependend on debt financing.
SISI's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. SISI is outperformed by 63.89% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.63
Debt/FCF	N/A
Altman-Z	-1.73

ROIC/WACCN/A

WACC4.2%

2.3 Liquidity

A Current Ratio of 0.72 indicates that SISI may have some problems paying its short term obligations.
The Current ratio of SISI (0.72) is worse than 91.67% of its industry peers.
SISI has a Quick Ratio of 0.72. This is a bad value and indicates that SISI is not financially healthy enough and could expect problems in meeting its short term obligations.
SISI's Quick ratio of 0.71 is on the low side compared to the rest of the industry. SISI is outperformed by 69.44% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.72
Quick Ratio	0.71

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SISI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1075.09%.
SISI shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.61%.
The Revenue for SISI have been decreasing by -20.68% on average. This is quite bad

EPS 1Y (TTM)-1075.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%92.31%

Revenue 1Y (TTM)73.61%

Revenue growth 3Y48.03%

Revenue growth 5Y-20.68%

Sales Q2Q%-96.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.